Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 5,203 shares at $175.23 ($923K) on 2026-09-24, disclosed to the SEC on 2026-09-25.
Scheduled sale ($923k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.23 | 2,485 | $435K | 47.2% |
| 2 | $176.39 | 945 | $167K | 18.1% |
| 3 | $177.17 | 164 | $29K | 3.1% |
| 4 | $178.67 | 330 | $59K | 6.4% |
| 5 | $179.93 | 143 | $26K | 2.8% |
| 6 | $180.39 | 515 |
| $93K |
| 10.1% |
| 7 | $181.45 | 21 | $4K | 0.4% |
| 8 | $182.50 | 16 | $3K | 0.3% |
| 9 | $183.76 | 501 | $92K | 10.0% |
| 10 | $184.60 | 83 | $15K | 1.7% |
| Total | $177.38 avg | 5,203 | $923K | 100% |
| Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |
| TWST | SELL | 2026-09-10 | $282K | — | Filing → |